Published in Gut on January 01, 1998
The Use of VSL#3 in Irritable Bowel Syndrome in Children (VSL#3) | NCT00932841
Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol (2006) 4.27
Yeasts in the gut: from commensals to infectious agents. Dtsch Arztebl Int (2009) 3.08
Gut microbiome-host interactions in health and disease. Genome Med (2011) 2.48
Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut (2003) 2.37
Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci (2000) 2.26
Toward a more complete (and less controversial) understanding of energy expenditure and its role in obesity pathogenesis. Diabetes (2011) 1.92
A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One (2012) 1.86
Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0-6 months. Arch Dis Child Fetal Neonatal Ed (2000) 1.68
Probiotics in patients with severe acute pancreatitis: a meta-analysis. Langenbecks Arch Surg (2008) 1.48
Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immun (2003) 1.48
Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically Ill trauma patients: early results of a randomized controlled trial. World J Surg (2006) 1.42
A prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients. Gut (2002) 1.36
Direct animal calorimetry, the underused gold standard for quantifying the fire of life. Comp Biochem Physiol A Mol Integr Physiol (2010) 1.34
Functional and probiotic attributes of an indigenous isolate of Lactobacillus plantarum. PLoS One (2009) 1.31
Characterization of microbial communities found in the human vagina by analysis of terminal restriction fragment length polymorphisms of 16S rRNA genes. Appl Environ Microbiol (2005) 1.29
The role of infection in the aetiology of inflammatory bowel disease. J Gastroenterol (2010) 1.26
In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrob Agents Chemother (2001) 1.24
Characterization of the groEL and groES loci in Bifidobacterium breve UCC 2003: genetic, transcriptional, and phylogenetic analyses. Appl Environ Microbiol (2004) 1.17
Bifidobacterium lactis DSM 10140: identification of the atp (atpBEFHAGDC) operon and analysis of its genetic structure, characteristics, and phylogeny. Appl Environ Microbiol (2004) 1.14
Escherichia coli acid resistance: pH-sensing, activation by chloride and autoinhibition in GadB. EMBO J (2006) 1.07
Commensal bacteria influence Escherichia coli O157:H7 persistence and Shiga toxin production in the mouse intestine. Infect Immun (2006) 1.06
Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients. Crit Care (2008) 1.06
Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol (2014) 1.04
Italian consensus conference for colonic diverticulosis and diverticular disease. United European Gastroenterol J (2014) 0.97
Assessment of a new synbiotic preparation in healthy volunteers: survival, persistence of probiotic strains and its effect on the indigenous flora. Nutr J (2003) 0.92
Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis. Open Med (2013) 0.91
A review of the functionality of probiotics in the larviculture food chain. Mar Biotechnol (NY) (2007) 0.88
Initiation of protein synthesis by a labeled derivative of the Lactobacillus casei DN-114 001 strain during transit from the stomach to the cecum in mice harboring human microbiota. Appl Environ Microbiol (2004) 0.88
Remission induction and maintenance effect of probiotics on ulcerative colitis: a meta-analysis. World J Gastroenterol (2010) 0.88
Preoperative synbiotic bowel conditioning for elective colorectal surgery. Wien Klin Wochenschr (2010) 0.88
Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon. Int J Colorectal Dis (2007) 0.88
Phenotypic variation in Blastocystis sp. ST3. Parasit Vectors (2014) 0.86
Enteral nutrition and acute pancreatitis: a review. Gastroenterol Res Pract (2010) 0.85
The protective effect of VSL#3 on intestinal permeability in a rat model of alcoholic intestinal injury. BMC Gastroenterol (2013) 0.85
Exposing to cadmium stress cause profound toxic effect on microbiota of the mice intestinal tract. PLoS One (2014) 0.85
The role of functional foods, nutraceuticals, and food supplements in intestinal health. Nutrients (2010) 0.84
Role of Glutamine in Protection of Intestinal Epithelial Tight Junctions. J Epithel Biol Pharmacol (2012) 0.84
Influences of enteral nutrition combined with probiotics on gut microflora and barrier function of rats with abdominal infection. World J Gastroenterol (2006) 0.83
Probiotics and Functional Foods in Gastrointestinal Disorders. Curr Treat Options Gastroenterol (2002) 0.83
Effect of bacterial flora on postimmunization gastritis following oral vaccination of mice with Helicobacter pylori heat shock protein 60. Clin Diagn Lab Immunol (2003) 0.83
Probiotics for antibiotic-associated diarrhea: do we have a verdict? World J Gastroenterol (2014) 0.83
Enhanced antigen-specific delayed-type hypersensitivity and immunoglobulin G2b responses after oral administration of viable Lactobacillus casei YIT9029 in Wistar and Brown Norway rats. Clin Diagn Lab Immunol (2001) 0.82
What does indirect calorimetry really tell us? Mol Metab (2014) 0.80
New strategies for the management of diverticular disease: insights for the clinician. Therap Adv Gastroenterol (2013) 0.78
Fecal bacterial microbiome diversity in chronic HIV-infected patients in China. Emerg Microbes Infect (2016) 0.77
Influence of maternal bifidobacteria on the development of gut bifidobacteria in infants. Pharmaceuticals (Basel) (2012) 0.77
Evolution of probiotics in aquatic world: Potential effects, the current status in Egypt and recent prospectives. J Adv Res (2013) 0.77
Alcoholic pancreatitis: A tale of spirits and bacteria. World J Gastrointest Pathophysiol (2014) 0.77
One cell, one love: a journal for microbial research. Microb Cell (2014) 0.75
Effect of the trehalose levels on the screening of yeast as probiotic by in vivo and in vitro assays. Braz J Microbiol (2008) 0.75
Preventing recurrent acute diverticulitis with pharmacological therapies. Ther Adv Chronic Dis (2013) 0.75
Probiotics inhibit immune fluctuation in the intestinal mucous layer in rats. Surg Today (2015) 0.75
Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med (1988) 16.74
Bacteriocins of gram-positive bacteria. Microbiol Rev (1995) 7.68
Emergence of vancomycin-resistant enterococci in New York City. Lancet (1993) 7.37
Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. Ann Intern Med (1987) 5.74
Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states. J Infect Dis (1991) 4.82
Early enteral feeding, compared with parenteral, reduces postoperative septic complications. The results of a meta-analysis. Ann Surg (1992) 4.26
Enteral versus parenteral feeding. Effects on septic morbidity after blunt and penetrating abdominal trauma. Ann Surg (1992) 3.85
The interaction of bacteria with mammalian cells. Annu Rev Cell Biol (1992) 3.62
Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol (1994) 3.61
Prospective studies of the effect of breast feeding on incidence of infection and allergy. Acta Paediatr Scand (1979) 3.55
Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J Infect Dis (1991) 3.17
Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res (1992) 3.15
The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. J Med Microbiol (1982) 3.04
Hospital-acquired infections: diseases with increasingly limited therapies. Proc Natl Acad Sci U S A (1994) 2.87
Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci (1992) 2.78
Evidence for an animal origin of vancomycin-resistant enterococci. Lancet (1993) 2.65
Total parenteral nutrition promotes bacterial translocation from the gut. Surgery (1988) 2.65
Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med (1995) 2.63
Intragastric nitric oxide production in humans: measurements in expelled air. Gut (1994) 2.53
Administration of different Lactobacillus strains in fermented oatmeal soup: in vivo colonization of human intestinal mucosa and effect on the indigenous flora. Appl Environ Microbiol (1993) 2.51
Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat Med (1995) 2.50
Antagonistic activities of lactic acid bacteria in food and feed fermentations. FEMS Microbiol Rev (1990) 2.37
Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr (1995) 2.30
Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery (1992) 2.26
Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis (1988) 2.16
The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet Gynecol (1992) 2.15
Diet and faecal flora in the newborn: breast milk and infant formula. Arch Dis Child (1989) 2.14
Acid Tolerance of Leuconostoc mesenteroides and Lactobacillus plantarum. Appl Environ Microbiol (1990) 2.00
Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet (1987) 1.88
The effect of dexamethasone administration on rat intestinal permeability: the role of bacterial adherence. Gastroenterology (1994) 1.71
Role of human microflora in health and disease. Eur J Clin Microbiol Infect Dis (1992) 1.64
A mannose-specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29. Appl Environ Microbiol (1996) 1.60
Enteral feeding of premature infants with Lactobacillus GG. Arch Dis Child (1993) 1.56
Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol (1995) 1.55
Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg (1995) 1.54
Factors influencing the presence of faecal lactobacilli in early infancy. Arch Dis Child (1990) 1.54
Modulation of cytotoxin production by Clostridium difficile in the intestinal tracts of gnotobiotic mice inoculated with various human intestinal bacteria. Appl Environ Microbiol (1985) 1.47
Numerical taxonomy of Lactobacillus spp. associated with healthy and diseased mucosa of the human intestines. J Appl Bacteriol (1993) 1.47
Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr (1995) 1.46
The attachment of bacteria to the gastric epithelium of the pig and its importance in the microecology of the intestine. J Appl Bacteriol (1980) 1.45
Effect of feeding on infants' faecal flora. Arch Dis Child (1982) 1.41
Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology (1993) 1.36
Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci (1994) 1.27
Fecal recovery in humans of viable Bifidobacterium sp ingested in fermented milk. Gastroenterology (1992) 1.24
Econutrition and health maintenance--a new concept to prevent GI inflammation, ulceration and sepsis. Clin Nutr (1996) 1.17
Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J Nutr (1994) 1.10
Multidrug-resistant Enterococcus faecium. An untreatable nosocomial pathogen. Drugs (1994) 1.10
Lessons learned from surveillance cultures in patients with acute nonlymphocytic leukemia. Usefulness for epidemiologic, preventive and therapeutic research. Am J Med (1981) 1.08
Lactobacilli and bacteremia in southern Finland, 1989-1992. Clin Infect Dis (1996) 1.07
Influence of maternal gut flora and colostral and cord serum antibodies on presence of Escherichia coli in faeces of the newborn infant. Acta Paediatr Scand (1976) 1.07
Arginine catabolism in Lactobacillus sake isolated from meat. Appl Environ Microbiol (1987) 1.05
Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia. A matched case-control study. Arch Intern Med (1993) 1.04
Antagonistic effects of lactobacilli and pediococci to control intestinal colonization by human enteropathogens in live poultry. J Appl Bacteriol (1991) 1.01
Two year oral use of chlorhexidine in man. II. The effect on the salivary bacterial flora. J Periodontal Res (1976) 0.99
Risk factors in early childhood for the development of atopic diseases. Allergy (1994) 0.96
Nutritional support to prevent and treat multiple organ failure. World J Surg (1996) 0.94
Immune and nutritional effects of early enteral nutrition after major abdominal operations. Eur J Surg (1996) 0.92
Microflora-derived polyamines modulate obstruction-induced colonic mucosal hypertrophy. Am J Physiol (1989) 0.91
Early postoperative enteral nutrition with arginine-omega-3 fatty acids and ribonucleic acid-supplemented diet versus placebo in cancer patients: an immunologic evaluation of Impact. Crit Care Med (1995) 0.91
Gastrointestinal surface protection and mucosa reconditioning. JPEN J Parenter Enteral Nutr (1996) 0.90
Influence of sputum IgA and elastase on tracheal cell bacterial adherence. Am Rev Respir Dis (1986) 0.88
Causes and consequences of bacterial adherence to mucosal epithelia during critical illness. New Horiz (1994) 0.85
Characteristics of the intestinal epithelial barrier during dietary manipulation and glucocorticoid stress. Crit Care Med (1996) 0.83
Augmented bacterial adherence to tracheal epithelial cells is associated with gram-negative pneumonia in an intensive care unit population. Am Rev Respir Dis (1989) 0.83
[The quantitative composition of the intestinal lactoflora before and after space flights of different lengths]. Nahrung (1984) 0.82
Analysis of severe infections (INF) after 180 consecutive liver transplants: the impact of amphotericin B prophylaxis for reducing the incidence and severity of fungal infections. Transplant Proc (1991) 0.81
Gut mucosa reconditioning with species-specific lactobacilli, surfactants, pseudomucus, and fibers--an invited review. Biotechnol Ther (1996) 0.78